|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2007-9-27
|
|
pubmed:abstractText |
Following extracellular drug clearance, we analyzed the rate of doxorubicin efflux from the nucleus of three human leukemic cells (K562, Molt4 and CCRF-CEM) and related it to their differential sensitivity to this drug, after a short drug pulse.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0724-8741
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2156-67
|
|
pubmed:dateRevised |
2011-8-11
|
|
pubmed:meshHeading |
pubmed-meshheading:17668300-Active Transport, Cell Nucleus,
pubmed-meshheading:17668300-Adenosine Triphosphate,
pubmed-meshheading:17668300-Ammonium Chloride,
pubmed-meshheading:17668300-Antibiotics, Antineoplastic,
pubmed-meshheading:17668300-Cell Line, Tumor,
pubmed-meshheading:17668300-Cell Nucleus,
pubmed-meshheading:17668300-Cell Survival,
pubmed-meshheading:17668300-Cytoplasm,
pubmed-meshheading:17668300-Doxorubicin,
pubmed-meshheading:17668300-Drug Resistance, Neoplasm,
pubmed-meshheading:17668300-Endocytosis,
pubmed-meshheading:17668300-Humans,
pubmed-meshheading:17668300-K562 Cells,
pubmed-meshheading:17668300-Membrane Fusion,
pubmed-meshheading:17668300-Metabolic Clearance Rate
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Rapid doxorubicin efflux from the nucleus of drug-resistant cancer cells following extracellular drug clearance.
|
|
pubmed:affiliation |
Department of Pharmaceutical Sciences, University of Michigan College of Pharmacy, 428 Church St., Ann Arbor, MI 48109, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
